Know Cancer

forgot password

Evaluation of Degree of Conversion of HER2 Receptor Between Primary Breast Cancer and Metastasis

18 Years
Not Enrolling
Breast Cancer

Thank you

Trial Information

Evaluation of Degree of Conversion of HER2 Receptor Between Primary Breast Cancer and Metastasis

Inclusion Criteria:

- Patients who have given their written informed consent to participate in the study.

- Women over 18 years.

- Breast cancer locally recurrent or metastatic at first relapse or after
successive progressions.

- Patient has to have available a sample of the primary tumor in paraffin.

- Patients who are planning for the next 6 weeks, the biopsy (fine needle
aspiration / drainage of fluid cavities, open biopsy, core biopsy) of locally
recurrent or metastatic lesion [local relapse in the chest wall, nodal ,
cutaneous or subcutaneous metastases, peripheral lymph nodes and other soft
tissues accessible, bone metastases, visceral metastases (lung, liver, brain,
etc..) or pleural effusion / ascites / pericardial / cerebrospinal] according to
clinical practice center.

Exclusion Criteria:

- Patients with cognitive impairment that might impede a proper understanding of the
written informed consent, according to medical criteria.

- ipsilateral breast local relapses or contralateral breast away.

- Patients diagnosed with a second neoplasm, with the exception of cervical carcinoma
in situ and non-melanoma skin carcinoma treated properly.

Type of Study:


Study Design:

Time Perspective: Prospective

Outcome Measure:

Evaluation of degree of conversion of HER2 receptor between primary breast cancer and metastases

Outcome Time Frame:

2 years since the beginning of the Study

Safety Issue:


Principal Investigator

Ana Lluch, MD

Investigator Role:

Study Chair

Investigator Affiliation:

Hospital Clinico Universitario de Valencia


Spain: Spanish Agency of Medicines

Study ID:




Start Date:

December 2009

Completion Date:

Related Keywords:

  • Breast Cancer
  • metastatic breast cancer
  • primary breast cancer
  • Breast Neoplasms
  • Neoplasm Metastasis